18 episodes

Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg
Isomorphic Labs president Max Jaderberg tells Elad Gil that drug discovery must move from empirical trial and error onto computers, using predictive AI models that reach experimental accuracy. AlphaFold was the first proof deep learning could generalize in biology, prompting Isomorphic's 2021 founding. He blames the empirical process for drugs costing $1.5 billion over 15 years with flat approvals, and clinic failures after rat toxicity tests prove only ~30% predictive. Isomorphic generates proprietary data, builds its drug design engine in-house, and focuses on oncology and immunology while partnering with pharma. He argues precise molecule engineering unlocks multidrug cocktails modulating whole pathways and expects predictive disease biology to step-change within five years.Nov 12, 2026 · 39:16 · 5.7K views
Tokenization, Agentic Trading, Harmonic: Robinhood's Mission to Expand Ownership with CEO Vlad Tenev
Robinhood CEO Vlad Tenev says the company's one-word mission is ownership, expanded from zero-commission stock trading into a global financial conglomerate in 120+ countries. He details tokenized stocks on Robinhood Chain bringing US equities to countries with weak capital markets, Agentic Trading's 150,000 accounts and 30 million daily tool calls putting hedge-fund tools in retail hands, plus prediction markets and KPI contracts that monetize knowledge directly. He explains Robinhood Ventures funds giving retail exposure to private AI companies, argues accredited-investor rules are outdated, and describes Trump accounts seeding $1,000 for every US newborn. Harmonic's Aristotle won International Math Olympiad gold; he argues decentralized discovery beats centralized AI labs.Nov 5, 2026 · 54:09 · 9.1K views
Taking on ServiceNow: Coding Agents for the Rest of Us with Serval Co-Founder and CEO Jake Stauch
Jake Stauch, co-founder and CEO of Serval, says his company can displace ServiceNow as the enterprise automation system of record with a code-gen platform that lets IT departments safely build automations. Serval layers deterministic approvals, staging, and audit trails over coding agents so large enterprises with strict permissions can adopt them; its ProServal team embeds automation engineers with customers for ongoing support. He explains why code beats drag-and-drop builders, why pricing on workflows run helps prove ROI, and why least-privilege access makes Serval more essential. He predicts personal agents entering enterprise via consumer trends, calls background agents an unsolved moonshot, and sees the SaaS-pocalypse as consolidation of point solutions, not SaaS's death.Oct 29, 2026 · 38:06 · 5K views
Democratizing Security for the Agentic Web with Cloudflare CTO Dane Knecht
Cloudflare CTO Dane Knecht tells Sarah Guo that AI has made vulnerability discovery relentless—once-yearly exploits now surface weekly, often from high schoolers with agents—pushing over 50% of engineering time to security for the next 18 months. He argues patching 70 years of software demands a redesigned development lifecycle and smaller attack surface, and that zero-trust architecture leaves enterprises better positioned. Calling the web a 'messy middle' where humans and agents share rails, he details Cloudflare's monetization gateway with agent wallets and a stablecoin plus Signals with OpenAI for CPM-style creator payments. He covers Cloudflare OS, a restructuring that folded a three-team email workflow into one tool, token budgeting, 1,000 interns, and four to five red teams.Oct 23, 2026 · 41:24 · 3.6K views
The New Apex Predator: CrowdStrike CEO George Kurtz on Adversaries Armed With AI Agents
CrowdStrike CEO George Kurtz tells hosts Sarah Guo and Elad Gil that AI agents have flattened the adversary pyramid: the 'agent state' gives hacktivists nation-state capability, with breakout time averaging 29 minutes and as fast as 27 seconds. Attackers favor guardrail-free open weight models like GLM and Qwen since attacks are 'not malware anymore, it's prompts,' and the Hugging Face incident showed defenders lack frontier capabilities. Kurtz explains CrowdStrike's SafeMind lab built with Nvidia on Nemotron, pitting red Tempest against blue Solano in a digital twin, and says its remediation costs $0.03 versus about $10 at frontier labs. He covers AIDR for shadow AI, agent identity and the shift to open weights, and argues AI won't require air-gapping the internet and will create more jobs.Oct 22, 2026 · 45:28 · 6.2K views
The Changing Physics of Cybersecurity and Drug Development with OpenAI President Greg Brockman
OpenAI president Greg Brockman joins Sarah Guo and Elad Gil to argue AI now generates genuinely new knowledge, citing nearly 400 century-old math problems solved and claiming the same capability can crack the language of biology. He says results transfer only where data exists, flagging regulatory filings and wet-lab data as bottlenecks. He describes Dots, a proactive always-on agent tracking his inbox and calendar, and argues the best UI is no UI as AI generates interfaces on the fly. On cybersecurity, he says defenders have a window to apply peak intelligence, citing OpenAI pulling 25% of production engineers and a billion-dollar defender commitment, and argues security spend should vastly outstrip software spend. He closes that humans stay firmly in the driver's seat as models surpass them.Oct 15, 2026 · 39:23 · 19.6K views
Beam: The Great American Open Model with ReflectionAI Co-Founder and CEO Misha Laskin
ReflectionAI co-founder and CEO Misha Laskin joins Sarah Guo to discuss Beam, the company's 500 billion parameter open-weight reasoning model, arguing open models will capture the majority of global token demand. He details Beam's training on 6,000 GB300s and RL on 10,000 GB300s for four weeks, making it 3-4X more reasoning-efficient than same-capability models, and says enterprises spending $100M-plus a year shift from renting to owning intelligence. He notes open tokens have flipped from 70-30 closed to 70-30 open, calls competition with China's open models healthy, and counters safety critiques citing Linus's Law and a closed model that hacked another company. He also describes AI compressing a multi-year PhD to a week and steady-state research teams of about 100 people.Oct 9, 2026 · 1:09:45 · 9.5K views
Frontier Chips for Frontier AI Labs, with Walter Goodwin, Founder/CEO of Fractile
Fractile founder and CEO Walter Goodwin tells Sarah Guo that full-stack chip design and a memory bandwidth bet—not flops—will drive the next leap in inference. Keeping architecture through physical design in-house at Fractile's 150-person team avoids Broadcom handoffs that leave hyperscaler ASICs like NVIDIA and AMD GPUs. Fractile pivoted from SRAM to a chip ramping in the second half of next year pairing DRAM's cost with Groq-like speed, aimed at long-running agents, not chatbots. Compressing the design cycle means more shots on goal—AI shrinks front-end work despite 3–5 month fab cycles—and a 3–6 month structural edge wins deployments. He sees bandwidth scaling laws enabling sparser MoEs and argues labs can't all-in on proprietary silicon: a rival breakthrough could kill them in nine months.Oct 2, 2026 · 35:39 · 9.9K views
Re-Founding Incumbents for the AI Era with Sequence Holdings Co-Founder and CEO Michael Lee
Sequence Holdings CEO Michael Lee tells Sarah Guo why incumbents, not startups, should lead AI transformation, and explains the $7.7 billion take-private of insurance broker Baldwin with the Dell Family Office. Lee argues enterprises can't recruit frontier engineering talent, can't trust incrementalist vendors, and can't buy software that hardens today's workflows—so Sequence buys incumbents and refounds them, one deal per year. He describes Atlas, Sequence's reusable platform of data ontology, agent building, and orchestration, and why brokerage economics resist startups. At BankSouth, underwriting time fell 94% in six months and loan closings dropped from 30 days to 11, letting volumes double. Lee closes with lessons from Apollo and Lone Pine: back exceptional people in big markets.Sep 24, 2026 · 42:45 · 7.9K views
Coinbase’s Everything Exchange: Agentic Finance, Stablecoins & Tokenization with CEO Brian Armstrong
Coinbase CEO Brian Armstrong argues his exchange is becoming the 'Everything Exchange' while preparing to bank AI agents. Armstrong tells Elad Gil that 88% of Coinbase revenue is non-Bitcoin trading, and details tokenized stocks, stablecoin payments settling in under one second for under $0.01, and prediction markets at a $100 million revenue run rate within months. He explains 76% of agentic commerce transactions are under $0.30, below card fee minimums; Coinbase built crypto wallets and the X402 protocol so agents can hold accounts and pay each other. He also describes Coinbase's internal AI 'brain' system for recursive self-improvement and New Limit, his longevity startup, whose epigenetic reprogramming platform begins a phase-one trial in alcoholic liver disease next year.Sep 10, 2026 · 45:10 · 8.9K views
Redefining Chip Architecture with Arm CEO Rene Haas
Arm CEO Rene Haas argues that the CPU, not the accelerator, remains the heart of every system: AI workloads still depend on microprocessors to orchestrate tokens, so Arm moved from licensing IP to building full compute subsystems, including the Arm AGI CPU for Meta. He says the shift was driven by customers like Meta who wanted complete solutions rather than components, and that Arm's design wins in smartphones, data centers and automobiles prove the model. Haas contends supply constraints in memory, substrates and advanced packaging will throttle industry growth for three to five years, making US fab capacity a national-security priority. He predicts AI will become a utility embedded in every device, from edge sensors to robots, and that fears of job loss are overstated because electricians, engineers and skilled tradespeople will be needed in greater numbers to build out data centers, fabs and the physical infrastructure AI requires.Sep 3, 2026 · 37:07 · 11.1K views
Rethinking Legacy Data Infrastructure with Eon Co-Founders Ofir Ehrlich and Gonen Stein
Eon co-founders Ofir Ehrlich and Gonen Stein join Elad Gil to argue that data, not compute or models, is the enterprise's moat, and their cloud backup now serves as a data foundation for AI. They cite Google's $10 million purchase of Spirit Airlines' data as proof that real-world data is gold, and say Eon maps, classifies, and masks scattered data to feed LLMs without breaking security or compliance. They warn that AI agents with legitimate permissions are creating ransomware-scale threats at extreme velocity, so companies must assume breach from non-human actors. They contrast the slow cloud era with today's faster, fear-driven AI adoption, where forward-deployed engineers and PLG reshape how legacy enterprises buy software. They say agents multiply actors, making dashboards essential.Aug 27, 2026 · 34:51 · 127.2K views
From Restoring Sight to Reimagining the Brain, with Max Hodak
Max Hodak, CEO of Science.xyz, tells Sarah Guo the brain is literally a computer, and his PRIMA retinal implant—just approved in Europe—restores formed vision to people blinded by macular degeneration by putting a chip under the retina that receives laser images from glasses. He argues this is the first step toward a BCI strategy focused on vision, hearing, balance, and motor control, not brain keyboards. Hodak ties consciousness to continuity rather than identity, making substrate independence the goal. He defends the Platonic Representation Hypothesis, saying AI model internals align with animal brain recordings, and outlines Science's pipeline—vision, biohybrid neural interfaces, and perfusion program VESSEL—to reduce human fragility and enable adapting to space.Aug 20, 2026 · 31:39 · 3.7K views
How Chess.com Became the World’s Biggest Chess Community with CEO Erik Allebest
Erik Allebest, CEO of Chess.com, tells host Sarah Guo how he turned a $56,000 bankruptcy-auction domain into a 250-million-member platform with 10 million daily users and $200M+ revenue. He bootstrapped after VCs called chess an uninvestable niche, and credits cultural spikes like Queen's Gambit and COVID for growth. General Atlantic and CVC bought secondary shares, keeping the company capital-light. He argues chess engines made the game more exciting, not obsolete, and AI now powers coaching, puzzles, and internal ops. He discusses Gambit, a poker site applying Chess.com ratings to prioritize skill over chips. He advises founders to ignore market dogma and offers cautious AGI optimism, stressing guardrails and cultural change.Aug 13, 2026 · 46:08 · 2.5K views
Chasing Trillion-Dollar Companies, Founder Ambition, Token Budgets, & Regulatory Capture
Sarah Guo and Elad Gil debate trillion-dollar company prospects, arguing that after Anthropic, OpenAI, and SpaceX hit that mark in five years, few more will repeat the pace; they see many hundred-billion-dollar opportunities. They urge founders not to retreat to niche markets out of fear of AI labs, and advise most to consider selling in a 12-to-18-month window if they aren't capturing value as costs fall. On compute, they frame token budgets as scarce, needing return-on-invested-tokens thinking. They assess lab belief that coding is solved within six months and light RSI by end of next year, while noting 18-month forecasts have repeatedly missed. Finally, they warn California's billionaire tax and exit-tax plans push founders to Texas, and that overcorrecting on AI safety risks repeating the regulatory capture that stalled nuclear power.Aug 6, 2026 · 39:30 · 9.2K views
Building an Autonomous Enterprise for Real-World Services with Netic Founder Melisa Tokmak
Melisa Tokmak, founder and CEO of Netic, tells Elad Gil how Netic's autonomous AI platform acts as an intermediary for essential services like HVAC, pet care, and roofing, with over 70% of customers now AI-first. She explains why she built a product company rather than an AI roll-up, and how selling to 'slow' industries is easier than assumed—they're value-focused and tech-forward. Big labs aren't threats due to focus and last-mile orchestration; robotics is decades away for these jobs. She screens for agency by asking candidates the hardest thing they've done, and sees private equity now demanding measurable ROI. Her five-year vision is an 'autonomous enterprise' where AI handles everything except physical labor; she is most excited about AI's impact on education and expanding agency.Jul 31, 2026 · 34:30 · 5.2K views
Building an Autonomous Delivery Experience with DoorDash Co-Founders Andy Fang and Stanley Tang
DoorDash co-founders Andy Fang and Stanley Tang explain how they are building an autonomous delivery ecosystem with their in-house robot Dot, which has operated at L4 autonomy in Phoenix for over two years, weighing 300 pounds and traveling 20 mph. They discuss how Ask DoorDash, a natural-language interface, drives 50% of restaurant trajectories to new places and 40% larger grocery basket sizes. The founders argue that a multimodal strategy—using Dot for 3-5 mile suburban deliveries, drones for rural areas, and Dashers for complex orders—is key, and that despite autonomy, DoorDash will have more Dashers in 10 years due to 25% annual growth and 9 million active Dashers. They emphasize that their advantage comes from combining world-class operations with real-world data from 10 billion deliveries, solving the first and last 100 feet problem that general-purpose autonomy companies overlook.Jul 23, 2026 · 49:20 · 4.3K views
Travel Through the Lens of AI with with Booking.com CEO Glenn Fogel
Booking Holdings CEO Glenn Fogel tells Elad Gil how he rode Priceline from the dot-com bust to a 1000x gain, arguing AI is a tool, not a threat, to travel. Fogel, who joined a week before the Nasdaq peaked, recalls the stock falling to $1 before a reverse split, and sees the same boom-bust pattern in AI. He shows how agentic tools like Priceline's Penny handle complex trips and cut customer service costs 10% per contact, while Booking invests $700 million in AI and tech. Yet he says there are no moats: scale like 8.6 million alternative accommodation listings only helps, and constant innovation is the only defense. He defends returning cash to shareholders—40% of shares bought back in a dozen years—and warns that AI job displacement demands upskilling, not rejection of technology.Jul 9, 2026 · 41:05 · 3.8K views
39:16Powering AI-Driven Drug Discovery with President of Isomorphic Labs Max Jaderberg
Isomorphic Labs president Max Jaderberg tells Elad Gil that drug discovery must move from empirical trial and error onto computers, using predictive AI models that reach experimental accuracy. AlphaFold was the first proof deep learning could generalize in biology, prompting Isomorphic's 2021 founding. He blames the empirical process for drugs costing $1.5 billion over 15 years with flat approvals, and clinic failures after rat toxicity tests prove only ~30% predictive. Isomorphic generates proprietary data, builds its drug design engine in-house, and focuses on oncology and immunology while partnering with pharma. He argues precise molecule engineering unlocks multidrug cocktails modulating whole pathways and expects predictive disease biology to step-change within five years.
Drug discovery and development has long relied on expensive, time-consuming empirical trial and error. By shifting the discovery process onto computers, Isomorphic Labs wants to fundamentally change medicine from a process of discovery to one of precision engineering. Elad Gil sits down with Isomorphic’s president Max Jaderberg to discuss his vision for using predictive AI models to achieve experimental accuracy. Max details how the success of AlphaFold provided the first proof of concept that a deep learning model could generalize in the field of biology, and how an AI model’s compounding of learnings allows it to achieve generalizability with scale, thus greatly increasing the probability of success as well as speed in real world clinical trials. He also talks about evolving past the need for animal testing through in-silico models, Isomorphic’s focus on developing drug design engines that are agnostic of disease area, target class, and modality, why accurate molecule engineering unlocks the potential for multidrug cocktails that span complex biological pathways, and how he believes AI molecule optimization will improve both human lifespan and healthspan. Sign up for new podcasts every week. Email feedback to show@no-priors.com Follow us on Twitter: @NoPriorsPod | @Saranormous | @EladGil | @MaxJaderberg | @IsomorphicLabs Chapters: 00:00 – Trailer 00:45 – Max Jaderberg Introduction 01:24 – Isomorphic Origins 05:23 – Drug Discovery Stagnation 11:49 – Hiring at Isomorphic 14:35 – Bringing Drug Discovery Onto Computers 19:31 – Isomorphic’s Datasets 20:30 – Rethinking Endpoints 22:50 – External vs. Internal Dependences 23:57 – Automating Biologic Labs 26:22 – Internal Development vs. Partnerships 27:19 – Areas of Human Health Focus 29:21 – Multidrug Approaches 32:17 – Risk Appetite Variation 34:26 – Disease Treatment Outlook 35:42 – Human Longevity and Drug Development 39:16 – Conclusion
